HotAvitag
Biotinylated Human ALPP Protein, His,Avitag™ (active enzyme, MALS verified)Cat. No. ALP-H82E3
| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| ALPP | HOTAvitag ALP-H82E3 | Biotinylated Human ALPP Protein, His,Avitag™ (active enzyme, MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $350.00 25ug | |
| ALPP | HOT ALP-H52H3 | Human ALPP Protein, His Tag (active enzyme, Mass Spec & MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $390.00 100ug | |
| ALPP | HOT ALP-R52H4 | Rat ALPP Protein, His Tag (active enzyme) | Rat | HEK293 | ![]() | SDS-PAGE | $390.00 100ug | |
| ALPP | Cynomolgus ALPP Protein, His Tag (active enzyme) | Cynomolgus | HEK293 | ![]() | SDS-PAGE | $390.00 100ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Retroviral vector-transduced autologous T cells to express anti-ALPP CARs (TCRCure Biopharma Corporation) | Phase 2 Clinical | Xinqiao Hospital, Army Medical University | Endometrial Neoplasms; Ovarian Neoplasms; Solid tumours | Details | |
| anti-ALPP CAR T-cell therapy (TCRCure Biopharma) | TC-A101 | Phase 1 Clinical | Tcrcure Biopharma Ltd | Solid tumours | Details |